Wahid Ali Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wahid Ali Khan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Mohd Wajid Ali Khan
Department of Chemistry, College of Sciences, University of Ha’il, Ha’il 55473, Saudi Arabia
11 shared publications Arshi Malik
Department of Clinical Biochemistry, College of Medicine, King Khalid University, Abha, Saudi Arabia
2 shared publications- Gaffar Sarwar Zaman
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Kingdom of Saudi Arabia.
2 shared publications Moinuddin
2 shared publicationsAbdullah S. Assiri
King Khalid University
1 shared publication- Abdulmohsen Khalaf Dhahi Alsukaibi
Department of Chemistry, College of Sciences, University of Ha’il, Ha’il 55473, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 1 November 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (11) , 1469
Pharmacological Activities of Zingiber officinale Roscoe: Inhibition of HSA Protein Glycation, Structure Stability and Function Restoration
Background: Controlled non-enzymatic glycation reactions are common under normal physiological conditions. However, during elevated blood glucose conditions, the glycation reactions are accelerated, leading to the formation of toxic compounds such as advanced glycation end products (AGEs). Several natural products are now being investigated as protective agents against glycation to preserve blood protein structure and functions. Methods: Human serum albumin (HSA) was glycated with 0.05 M α-D-glucose alone or in the presence of Zingiber officinale Roscoe (ginger) extract (0.781–100 μg/mL) for 10 weeks, and biochemical, biophysical, and computational analyses were carried out. Results: HSA glycated for 10 weeks (G-HSA-10W) resulted in significant production of ketoamines, carbonyl compounds, and AGE pentosidine. Notable structural alterations were observed in G-HSA-10W, ascertained by ultraviolet (UV), fluorescence, and circular dichroism (CD) studies. Antioxidant, anti-glycating, AGEs inhibitory, and antibacterial effects of ginger extracts were observed and attributed to the presence of various phytochemicals. Molecular docking studies suggested that the compounds 8-shagaol and gingerol exhibited strong and multiple interactions with HSA. Molecular simulation analysis suggests HSA attains a high degree of conformational stability with the compounds gingerol and 8-shogaol. Conclusions: These findings showed that ginger extract has an antioxidant function and can prevent glycation-induced biochemical and biophysical alterations in HSA. Thus, aqueous ginger extract can be utilized to combat glycation and AGE-related health issues, especially diabetes, neurological disorders, inflammatory diseases, etc.
- 1 November 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (11) , 1469
Open AccessPharmacological Activities of Zingiber officinale Roscoe: Inhibition of HSA Protein Glycation, Structure Stability and Function Restoration
Background: Controlled non-enzymatic glycation reactions are common under normal physiological conditions. However, during elevated blood glucose conditions, the glycation reactions are accelerated, leading to the formation of toxic compounds such as advanced glycation end products (AGEs). Several natural products are now being investigated as protective agents against glycation to preserve blood protein structure and functions. Methods: Human serum albumin (HSA) was glycated with 0.05 M α-D-glucose alone or in the presence of Zingiber officinale Roscoe (ginger) extract (0.781–100 μg/mL) for 10 weeks, and biochemical, biophysical, and computational analyses were carried out. Results: HSA glycated for 10 weeks (G-HSA-10W) resulted in significant production of ketoamines, carbonyl compounds, and AGE pentosidine. Notable structural alterations were observed in G-HSA-10W, ascertained by ultraviolet (UV), fluorescence, and circular dichroism (CD) studies. Antioxidant, anti-glycating, AGEs inhibitory, and antibacterial effects of ginger extracts were observed and attributed to the presence of various phytochemicals. Molecular docking studies suggested that the compounds 8-shagaol and gingerol exhibited strong and multiple interactions with HSA. Molecular simulation analysis suggests HSA attains a high degree of conformational stability with the compounds gingerol and 8-shogaol. Conclusions: These findings showed that ginger extract has an antioxidant function and can prevent glycation-induced biochemical and biophysical alterations in HSA. Thus, aqueous ginger extract can be utilized to combat glycation and AGE-related health issues, especially diabetes, neurological disorders, inflammatory diseases, etc.
- Open Access
- 1 January 2021
- Published by MRE Press in Journal of Men's Health
- Vol. 17 (4) , 117-127
16α-hydroxyestrone and its receptor complex: high affinity antigen for antibodies from prostate cancer patients
Journal of Men's Health (JOMH) is the official journal of the International Society of Men's Health (ISMH). JOMH is a peer-reviewed, open-access journal that covers all aspects of men's health
- 1 January 2021
- Published by MRE Press in Journal of Men's Health
- Vol. 17 (4) , 117-127
Open Access16α-hydroxyestrone and its receptor complex: high affinity antigen for antibodies from prostate cancer patients
Journal of Men's Health (JOMH) is the official journal of the International Society of Men's Health (ISMH). JOMH is a peer-reviewed, open-access journal that covers all aspects of men's health
- 1 September 2020
- Published by Elsevier in International Immunopharmacology
- Vol. 86, 106712
Depression linked to higher antibodies production against estrogenized insulin in type 1 diabetes
- 1 September 2020
- Published by Elsevier in International Immunopharmacology
- Vol. 86, 106712
Depression linked to higher antibodies production against estrogenized insulin in type 1 diabetes
- 1 September 2020
- Published by Elsevier in Life Sciences
- Vol. 256, 117910
Estrogenization of insulin by catecholestrogen produced high affinity autoantibodies and altered the normal function of insulin in type 1 diabetes
- 1 September 2020
- Published by Elsevier in Life Sciences
- Vol. 256, 117910
Estrogenization of insulin by catecholestrogen produced high affinity autoantibodies and altered the normal function of insulin in type 1 diabetes
- 6 August 2020
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 46 (10) , 2115-2125
Endometrial cancer patients have high affinity antibodies for estrogen metabolite–receptor aggregate: A potential biomarker for EC
Aim Elevated levels of 16 alpha-hydroxyestrone (16 alpha-OHE1) have been described in endometrial cancer (EC) and estrogen receptors (ER) expressed in endometrial tissue, but research on their combined role is lacking. We aimed to investigate the affinity and binding specificity of EC antibodies against the 16 alpha-OHE1-ER alpha aggregate in the serum of EC patients. Specificities of EC antibodies were also evaluated according to various clinical characteristics found in these cancer patients. Methods The binding specificity and affinity of EC antibodies against 16 alpha-OHE1-ER alpha in the serum of 120 EC patients were evaluated by direct binding and competition ELISA and quantitative precipitation titration. Binding of EC antibodies was also determined according to various clinical characteristics in EC patients through competition ELISA. Results Antibodies from EC patients demonstrated high recognition of 16 alpha-OHE1-ER alpha compared to ER alpha (P < 0.05) or 16 alpha-OHE1(P < 0.001). The relative affinity of EC IgG was 1.49 x 10(-7) M, 1.34 x 10(-6) M and 1.13 x 10(-6) M for 16 alpha-OHE1-ER alpha, ER alpha and 16 alpha-OHE1, respectively. Several factors, such as obesity, postmenopausal status, use of hormonal therapy, ER and progesterone receptor (PR) status, low 2-OHE1/16 alpha-OHE(1)ratio, chemotherapy and hypertension, augment the production of antibodies against 16 alpha-OHE1-ER alpha in EC patients. Conclusion 16 alpha-OHE1-ER alpha is a high-affinity antigen for EC antibodies in the serum of EC patients and might function as a biomarker for this disease. Furthermore, several factors enhanced the production of antibodies against 16 alpha-OHE1-ER alpha in the sera of these EC patients.
- 6 August 2020
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 46 (10) , 2115-2125
Endometrial cancer patients have high affinity antibodies for estrogen metabolite–receptor aggregate: A potential biomarker for EC
Aim Elevated levels of 16 alpha-hydroxyestrone (16 alpha-OHE1) have been described in endometrial cancer (EC) and estrogen receptors (ER) expressed in endometrial tissue, but research on their combined role is lacking. We aimed to investigate the affinity and binding specificity of EC antibodies against the 16 alpha-OHE1-ER alpha aggregate in the serum of EC patients. Specificities of EC antibodies were also evaluated according to various clinical characteristics found in these cancer patients. Methods The binding specificity and affinity of EC antibodies against 16 alpha-OHE1-ER alpha in the serum of 120 EC patients were evaluated by direct binding and competition ELISA and quantitative precipitation titration. Binding of EC antibodies was also determined according to various clinical characteristics in EC patients through competition ELISA. Results Antibodies from EC patients demonstrated high recognition of 16 alpha-OHE1-ER alpha compared to ER alpha (P < 0.05) or 16 alpha-OHE1(P < 0.001). The relative affinity of EC IgG was 1.49 x 10(-7) M, 1.34 x 10(-6) M and 1.13 x 10(-6) M for 16 alpha-OHE1-ER alpha, ER alpha and 16 alpha-OHE1, respectively. Several factors, such as obesity, postmenopausal status, use of hormonal therapy, ER and progesterone receptor (PR) status, low 2-OHE1/16 alpha-OHE(1)ratio, chemotherapy and hypertension, augment the production of antibodies against 16 alpha-OHE1-ER alpha in EC patients. Conclusion 16 alpha-OHE1-ER alpha is a high-affinity antigen for EC antibodies in the serum of EC patients and might function as a biomarker for this disease. Furthermore, several factors enhanced the production of antibodies against 16 alpha-OHE1-ER alpha in the sera of these EC patients.
- Open Access
- 24 April 2019
- Published by IntechOpen
Introductory Chapter: Autoantibodies and Their Types
Open access peer-reviewed chapter
- 24 April 2019
- Published by IntechOpen
Open AccessIntroductory Chapter: Autoantibodies and Their Types
Open access peer-reviewed chapter
- Open Access
- 24 April 2019
- Published by IntechOpen
Autoantibodies and Cytokines in Pathogenesis of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is an autoimmune disorder in which increased autoantibody production and enhanced secretion of pro-inflammatory cytokines are the hallmark of the disease. A strictly controlled balance of antibody production and proinflammatory cytokines is the key to the healthy state. A slight tilt in this balance causes proinflammatory diseases. In RA there is an increased production of autoantibodies such as rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA), anti-cartilage type II antibodies, and etc., which have a prominent clinical significance. Furthermore, there is increased secretion of proinflammatory cytokines such as tumor necrosis factor-α (TNFα), interleukin-6 (IL-6), interleukin-1 (IL-1) which have an impact of great magnitude on the RA disease progression and severity. A better understanding of the mechanism of autoantibody production and secretion of cytokines together with crosstalk between immune cells and cytokines can provide us a better insight into the disease pathogenesis as well disease prognosis and management.
- 24 April 2019
- Published by IntechOpen
Open AccessAutoantibodies and Cytokines in Pathogenesis of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is an autoimmune disorder in which increased autoantibody production and enhanced secretion of pro-inflammatory cytokines are the hallmark of the disease. A strictly controlled balance of antibody production and proinflammatory cytokines is the key to the healthy state. A slight tilt in this balance causes proinflammatory diseases. In RA there is an increased production of autoantibodies such as rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA), anti-cartilage type II antibodies, and etc., which have a prominent clinical significance. Furthermore, there is increased secretion of proinflammatory cytokines such as tumor necrosis factor-α (TNFα), interleukin-6 (IL-6), interleukin-1 (IL-1) which have an impact of great magnitude on the RA disease progression and severity. A better understanding of the mechanism of autoantibody production and secretion of cytokines together with crosstalk between immune cells and cytokines can provide us a better insight into the disease pathogenesis as well disease prognosis and management.
- 1 March 2019
- Published by Elsevier in Advances in Medical Sciences
- Vol. 64 (1) , 72-78
16 α-Hydroxyestrone induced adduct generate high affinity autoantibodies in SLE
- 1 March 2019
- Published by Elsevier in Advances in Medical Sciences
- Vol. 64 (1) , 72-78
16 α-Hydroxyestrone induced adduct generate high affinity autoantibodies in SLE
- 27 November 2018
- Published by Elsevier in International Immunopharmacology
- Vol. 66, 251-259
Depression enhanced the production of autoantibodies against 16α‑hydroxyestrone-estrogen receptor adduct in breast cancer
- 27 November 2018
- Published by Elsevier in International Immunopharmacology
- Vol. 66, 251-259
Depression enhanced the production of autoantibodies against 16α‑hydroxyestrone-estrogen receptor adduct in breast cancer